Here is a new pre-print making the "Conclusion: COVID-19 in solid organ transplant patients probably has a more disease severity, worse major outcomes (Intensive care admission, invasive ventilation, acute kidney injury), and higher mortality than in non-transplant patients."

Looking at the UCLA eINDs, there were 5 transplant patients. 4 survived past 30 days; the one death was 79 years old, type 2 diabetes and chronic kidney disease.

More evidence leronlimab being able to reduce mortality for high mortality groups.

https://www.researchgate.net/publication/3486...ing_Review